Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRI Assessment of Orkambi in CF
NCT03956589Phase 4Terminated
- Start
- Oct 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lumacaftor + ivacaftor in cystic fibrosis (CF). Started Oct 2018; status: terminated.
02
Drugs
lumacaftor + ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03956589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03956589.